PCSK9 and type 2 diabetes mellitus: HMGCR, NPC1L1 and PCSK9 all lowered risk of CAD, yet HMGCR, and to a lesser extent NPC1L1 and PCSK9, increased risk of T2D (as presented in Fig 2).